Palisade Bio
PALI
12 hedge funds and large institutions have $103K invested in Palisade Bio in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
79% more capital invested
Capital invested by funds: $57.5K → $103K (+$45.3K)
9% more funds holding
Funds holding: 11 → 12 (+1)
0.45% less ownership
Funds ownership: 1.76% → 1.31% (-0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$10.5K |
| 3 |
Morgan Stanley
New York
|
+$6.73K |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$1.95K |
| 5 |
Citigroup
New York
|
+$1.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$10.4K |
| 2 |
T
Transce3nd
Kyle,
Texas
|
-$680 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $25.3K | +$10.5K | +13,437 | +84% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $22.9K | +$1.48K | +1,888 | +8% |
|
|
3
UBS Group
Zurich,
Switzerland
| $16.7K | +$14.9K | +19,081 | +5,747% |
|
|
XT
4
XTX Topco
George Town,
Cayman Islands
| $12.1K | -$10.4K | -13,252 | -48% |
|
|
NFSG
5
Newbridge Financial Services Group
Boca Raton,
Florida
| $11.2K | +$1.95K | +2,500 | +24% |
|
|
6
Morgan Stanley
New York
| $7.41K | +$6.73K | +8,611 | +123,014% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $4.64K | +$648 | +829 | +18% |
|
|
8
Citigroup
New York
| $2.02K | +$1.83K | +2,347 | New |
|
9
Rockefeller Capital Management
New York
| $430 | +$391 | +500 | New |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $86 | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $73 | +$32 | +41 | +91% |
|
12
Wells Fargo
San Francisco,
California
| $18 | – | – | – |
|
|
T
13
Transce3nd
Kyle,
Texas
| – | -$680 | -1,000 | Closed |
|
PALI Hedge Fund Activity: Q3 2025 in Review
12 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2025, worth a combined $103K — up 79% from $57.5K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PALI positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $14.9K. The largest seller was XTX Topco, cutting an estimated $10.4K.
- 12 institutional investors held Palisade Bio (PALI) as of Q3 2025, up from 11 in Q2 2025.
- Funds reported $103K of Palisade Bio stock for Q3 2025, up 79% quarter-over-quarter.
- 2 funds opened new Palisade Bio positions in Q3 2025 and 1 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q3 2025 was UBS Group, an estimated $14.9K added.
- The largest Palisade Bio seller in Q3 2025 was XTX Topco, an estimated $10.4K sold.
Based on aggregated 13F filings for Q3 2025.